Inventors list |
Agents list |
Assignees list |
List by place |
Classification tree browser |
Top 100 Inventors |
Top 100 Agents |
Top 100 Assignees |
HOFFMANN-LA ROCHE INC.;PATENT LAW DEPARTMENT
NUTLEY, NJ US
1. 20110046122 3-AMINO-5-PHENYL-5,6-DIHYDRO-2H-[1,4]OXAZINES 02-24-20112. 20110046112 NOVEL BICYCLIC SULFONAMIDE DERIVATIVES WHICH ARE L-CPT1 INHIBITORS 02-24-2011
3. 20110045510 PEGYLATED INSULIN-LIKE-GROWTH-FACTOR ASSAY 02-24-2011
4. 20110044909 ANIMAL MODEL FOR DIABETES - method of producing diabetic mice and their use in drug development 02-24-2011
5. 20110040091 PROCESS FOR THE PREPARATION OF (R)-2-PHENYL PROPIONIC ACID DERIVATIVES 02-17-2011
6. 20110034672 PURIFICATION OF NOT-GLYCOSYLATED POLYPEPTIDES 02-10-2011
7. 20110034470 Inhibitors of JNK - JNK inhibitors and corresponding methods formulations and compositions for inhibiting JNK and treating JNK-mediated disorders 02-10-2011
8. 20110028524 PHARMACEUTICAL COMPOSITIONS FOR POORLY SOLUBLE DRUGS 02-03-2011
9. 20110028515 NEW PIPERIDINE DERIVATIVES - Compounds of formula STR00001 as well as pharmaceutically acceptable salts thereof can be used in the form of 02-03-2011
10. 20110028511 PROCESS FOR THE MANUFACTURE OF PHARMACEUTICALLY ACTIVE COMPOUNDS 02-03-2011
11. 20110027374 CAPECITABINE RAPIDLY DISINTEGRATING TABLETS 02-03-2011
12. 20110027190 COMPOSITION OF A FIRST NON-LABELED MONOCLONAL ANTIBODY BINDING TO A TUMOR ANTIGEN AND A NON-CROSS REACTIVE SECOND MONOCLONAL ANTIBODY LABELED WITH A NIR FLUORESCENCE LABEL 02-03-2011
13. 20110021570 PYRIDONE GLUCOKINASE ACTIVATORS - Provided herein are compounds of the formula : STR00001 as well as pharmaceutically acceptable salts thereof 01-27-2011
14. 20110021565 PIPERIDINE DERIVATIVES AS NK3 ANTAGONISTS 01-27-2011
15. 20110021425 TRICYCLIC INHIBITORS OF JAK - the use of novel compounds of Formulae I-II, STR00001 wherein the variables R, X 01-27-2011
16. 20110015234 INDAZOLE DERIVATIVES - The invention is concerned with novel indazole derivatives of formula STR00001 wherein R 01-20-2011
17. 20110015202 IMIDAZOLES - imidazole derivatives of the general formula STR00001 wherein R 01-20-2011
18. 20110009317 CONJUGATES OF INSULIN-LIKE GROWTH FACTOR-1 AND POLY(ETHYLENE GLYCOL) 01-13-2011
19. 20110004011 NOVEL PROCESS - process for the preparation of S-[2-[1-cyclohexylcarbonylamino]-phenyl]2-methylthiopropion- ate which is a useful pharmaceutical active 01-06-2011
20. 20100331371 METHYL-BENZIMIDAZOLE DERIVATIVES - The invention is concerned with novel substituted benzimidazole derivatives of formula STR00001 wherein R 12-30-2010
21. 20100323427 INSULIN DEGRADING ENZYME CRYSTALS - apo crystals and co-crystals of insulin-degrading enzyme and their uses in drug development 12-23-2010
22. 20100323373 METHOD FOR THE ASSESSMENT OF THE INHIBITORY ACTIVITY OF ANTIBODIES AGAINST INSULIN-LIKE GROWTH FACTOR I RECEPTOR 12-23-2010
23. 20100322934 Bispecific, Tetravalent Antigen Binding Proteins 12-23-2010
24. 20100322927 GLYCOSYLATED ANTIBODIES - antibody comprising human IgG1 or IgG3 heavy chain constant domains that are glycosylated with a sugar chain at Asn297 12-23-2010
25. 20100317647 NOVEL CYCLOPENTANE DERIVATIVES - compound of formula STR00001 wherein A 12-16-2010
26. 20100316645 Bispecific Antigen Binding Proteins - methods for their production 12-16-2010
27. 20100311971 SOLID FORMS OF [4-(3-FLUORO-5-TRIFLUOROMETHYL-PYRIDIN-2-YL)-PIPERAZIN-1-YL-[5-METHANESUL- FONYL-2-((S)-2,2,2-TRIFLUORO-1-METHYL-ETHOXY)-PHENYL]-METHANONE 12-09-2010
28. 20100310567 Antibodies Against Human CCN1 and Uses Thereof 12-09-2010
29. 20100306868 QUADRUPLE TRANSGENIC NON-HUMAN ANIMAL - transgenic non-human animal whose genome comprises 12-02-2010
30. 20100304400 DISTINGUISHING ASSAY - The current invention comprises a method for determining of an antibody against a drug antibody in a sample using an immunoassay 12-02-2010
31. 20100303802 ANTIBODY DIRECTED TO G PROTEIN COUPLED RECEPTORS (GPCR) 12-02-2010
32. 20100292247 HETEROCYCLYL PYRIDYL SULFONAMIDE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS 11-18-2010
33. 20100292212 NEW AZACYCLIC DERIVATIVES - compounds of formula STR00001 and pharmaceutically acceptable salts thereof, wherein n, m, A, R 11-18-2010
34. 20100286396 NOVEL ISOQUINOLINE DERIVATIVES - The invention provides novel compounds of formula STR00001 or a pharmaceutically acceptable salt thereof, wherein R 11-11-2010
35. 20100286159 PYRIDAZINES - The present invention is concerned with isoxazole-pyridazines of formula I, having affinity and selectivity for GABA A 11-11-2010
36. 20100286158 DIHYDROPYRIMIDINONES - This invention relates to dihydropyrimidinones of the formula STR00001 wherein X and R 11-11-2010
37. 20100286132 PYRIDINES - The present invention is concerned with isoxazole-pyridines of formula I, having affinity and selectivity for GABA A 11-11-2010
38. 20100286117 PYRIDINES - The present invention is concerned with novel isoxazoles of formula I STR00001 wherein X, R 11-11-2010
39. 20100286116 THIAZOLES - The present invention is concerned with isoxazole-thiazole derivatives of formula I, having affinity and selectivity for GABA A 11-11-2010
40. 20100286115 PYRAZOLES - The present invention is concerned with isoxazole-pyrazoles of formula I having affinity and selectivity for GABA A a5 receptor 11-11-2010
41. 20100280021 PYRIDOPYRIMIDINE PROTEIN TYROSINE PHOSPHATASE INHIBITORS 11-04-2010
42. 20100280020 ISOXAZOLES - The present invention is concerned with novel isoxazole derivatives of formula I STR00001 wherein X, R 11-04-2010
43. 20100280019 ISOXAZOLES - The present invention is concerned with novel isoxazole derivatives of formula I STR00001 wherein X, R 11-04-2010
44. 20100273819 3,3'-Spiroindolinone Derivatives - There are provided compounds of the formula STR00001 or a pharmaceutically acceptable salt or ester thereof wherein 10-28-2010
45. 20100273768 Inhibitors of Bruton's Tyrosine Kinase - This application discloses 5-phenyl-1H-pyridin-2-one 6-phenyl-2H-pyridazin-3-one and 5-phenyl-1H-pyrazin-2-one 10-28-2010
46. 20100267745 3-Pyridinecarboxamide Derivatives as HDL-Cholesterol Raising Agents 10-21-2010
47. 20100267722 NOVEL PROLINE DERIVATIVES - compound of formula STR00001 wherein A, R 10-21-2010
48. 20100267666 Pyrrolopyrazine kinase inhibitors - the use of novel pyrrolopyrazine derivatives of Formula I, STR00001 wherein the variables Q 10-21-2010
49. 20100261216 STABILITY TESTING OF ANTIBODIES - Antibodies are biological macromolecules which may be subject to modification and degradation processes 10-14-2010
50. 20100256340 TRIVALENT, BISPECIFIC ANTIBODIES - trivalent bispecific antibodies methods for their production 10-07-2010
51. 20100256339 Bispecific Anti ErbB3 / Anti cMet Antibodies 10-07-2010
52. 20100256338 MULTISPECIFIC ANTIBODIES COMPRISING FULL LENGTH ANTIBODIES AND SINGLE CHAIN FAB FRAGMENTS 10-07-2010
53. 20100256200 ARYL PYRIDYL SULFONAMIDE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS 10-07-2010
54. 20100256154 ISOXAZOLO-PYRAZINE DERIVATIVES - and their pharmaceutically acceptable salts having affinity and selectivity for the GABA A 10-07-2010
55. 20100256140 INDOL-3-YL-CARBONYL-PIPERIDIN-BENZOIMIDAZOL DERIVATIVES 10-07-2010
56. 20100256127 SUBSTITUTED ISOXAZOLES - The present invention is concerned with novel hydroxy-methyl isoxazole derivatives of formula I STR00001 wherein R 10-07-2010
57. 20100256126 PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS 10-07-2010
58. 20100255008 ANTIBODIES AGAINST HUMAN TWEAK AND USES THEREOF 10-07-2010
59. 20100254989 Bispecific Anti ErbB1 / Anti c Met Antibodies 10-07-2010
60. 20100254988 Bispecific Anti ErbB2 / Anti cMet Antibodies 10-07-2010
61. 20100249428 PROCESS FOR THE PREPARATION OF PROPIONIC ACID DERIVATIVES 09-30-2010
62. 20100249384 IMMUNOGLOBULIN AGGREGATES - The current invention reports a method for concentrating an immunoglobulin solution by tangential flow filtration wherein 09-30-2010
63. 20100249379 PROTEIN EXPRESSION FROM MULTIPLE NUCLEIC ACIDS 09-30-2010
64. 20100249139 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS 09-30-2010
65. 20100249124 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS 09-30-2010
66. 20100247533 TREATMENT WITH A HUMANIZED ANTI-EGFR IgG1 ANTIBODY AND IRINOTECAN 09-30-2010
67. 20100247484 COMBINATION THERAPY OF AN AFUCOSYLATED ANTIBODY AND ONE OR MORE OF THE CYTOKINES GM CSF, M CSF AND/OR IL3 09-30-2010
68. 20100240678 LEUKOTRIENE B4 INHIBITORS - Provided herein are compounds of the formula : STR00001 as well as pharmaceutically acceptable salts thereof 09-23-2010
69. 20100227887 PYRIDINE-2-YL CARBOXYLIC ACID AMIDES - pyridine-2-yl-carboxylic acid amides which act as metabotropic glutamate receptor antagonists 09-09-2010
70. 20100222357 INDOL-3-Y-CARBONYL-PIPERIDIN AND PIPERAZIN-DERIVATIVES 09-02-2010
71. 20100222350 PHENYL, PYRIDINE, QUINOLINE, ISOQUINOLINE, NAPHTHYRIDINE AND PYRAZINE DERIVATIVES 09-02-2010
72. 20100222340 SUBSTITUTED PYRIDO [1,2-a] ISOQUINOLINE DERIVATIVES 09-02-2010
73. 20100222325 Inhibitors of Bruton's Tyrosine Kinase - This application discloses 5-phenyl-1H-pyridin-2-one 6-phenyl-2H-pyridazin-3-one and 5-Phenyl-1H-pyrazin-2-one 09-02-2010
74. 20100221781 CHO-K1 CELL LINE - The current invention reports a CHO-K1 cell characterized in that said CHO-K 1 cell is derived from CHO-K1 cell deposited as ATCC 09-02-2010
75. 20100216845 ISOXAZOLES / O-PYRIDINES WITH ETHYL AND ETHENYL LINKER 08-26-2010
76. 20100216833 TETRAHYDROCARBAZOLES AND DERIVATIVES - compounds of the formula STR00001 wherein R 08-26-2010
77. 20100216806 ORTHO AMINOAMIDES FOR THE TREATMENT OF CANCER 08-26-2010
78. 20100216793 HETEROARYL SUBSTITUTED PYRIDAZINONE DERIVATIVES 08-26-2010
79. 20100210674 Spiroindolinone Derivatives - There are provided compounds of the formula STR00001 or a pharmaceutically acceptable salt or ester thereof wherein X, Y, 08-19-2010
80. 20100210659 PYRROLIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS 08-19-2010
81. 20100210651 ISOXAZOLE-ISOXAZOLES AND ISOXAZOLE-ISOTHIAZOLES 08-19-2010
82. 20100210642 ACETYLENYL-PYRAZOLO-PYRIMIDINE DERIVATIVES 08-19-2010
83. 20100210592 AMINES OR AMINO ALCOHOLS AS GLYT1 INHIBITORS 08-19-2010
84. 20100210547 METHOD FOR THE PRODUCTION OF CONJUGATES OF INSULIN-LIKE GROWTH FACTOR-1 AND POLY(ETHYLENE GLYCOL) 08-19-2010
85. 20100204257 SPIROINDOLINONE PYRIDINE DERIVATIVES - There are provided compounds of the formula STR00001 or a pharmaceutically acceptable salt, ester or enantiomer 08-12-2010
86. 20100204233 IMIDAZOLE DERIVATIVES - which have a good affinity to the trace amine associated receptors , especially for TAAR1 08-12-2010
87. 20100203554 GENERIC KINASE/PHOSPHATASE ASSAY WITH SINGLE READOUT 08-12-2010
88. 20100197773 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF PTP1B GENES 08-05-2010
89. 20100197715 PIPERIDINE DERIVATIVES - compound of formula I STR00001 wherein R 08-05-2010
90. 20100197697 PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS 08-05-2010
91. 20100197637 Method of Treatment Using Bisphosphonic Acid 08-05-2010
92. 20100196961 VARIABLE TANGENTIAL FLOW FILTRATION - The current invention reports a method for concentrating an immunoglobulin solution by tangential flow filtration 08-05-2010
93. 20100196931 DETERMINATION OF RESPONDERS TO CHEMOTHERAPY 08-05-2010
94. 20100190976 NOVEL PROCESS FOR THE RECOVERY OF BETA ACETYLFURANOSIDE 07-29-2010
95. 20100190835 PHARMACEUTICAL COMPOSITION COMPRISING ALEGLITAZAR 07-29-2010
96. 20100190814 SPIROINDOLINONE DERIVATIVE PRODRUGS - There are provided compounds of the formula STR00001 and pharmaceutically acceptable salts and esters and 07-29-2010
97. 20100184716 PHARMACEUTICAL COMPOSITIONS WITH SUPERIOR PRODUCT PERFORMANCE AND PATIENT COMPLIANCE 07-22-2010
98. 20100184144 IMMUNOGLOBULIN PRODUCTION - The current invention comprises a nucleic acid encoding the amino acid sequence of the C-terminal part of the C 07-22-2010
99. 20100183876 Process for the Preparation of a Peptide Powder Form 07-22-2010
100. 20100179093 Neoropeptide-2-Receptor (Y-2R) Agonists - Provided herein are neuropeptide-2 receptor agonists of the formula : STR00001 as well as pharmaceutically 07-15-2010
101. 20100178672 CHO CELL - The current invention comprises a CHO cell which is expressing a constitutively active mitogenic receptor 07-15-2010
102. 20100168181 BENZIMIDAZOLE AMIDO DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS 07-01-2010
103. 20100168088 PYRROLIDINE DERIVATIVES AS NK-3 RECEPTOR ANTAGONISTS 07-01-2010
104. 20100167313 ANTI-IDIOTYPE ANTIBODY AGAINST AN ANTIBODY AGAINST THE AMYLOID BETA PEPTIDE 07-01-2010
105. 20100160441 NOVEL COMPOUNDS - The invention is concerned with compounds of formula I: STR00001 wherein R, R 06-24-2010
106. 20100160308 Thiazolyl-Benzimidazoles - The invention is directed to compounds of formula STR00001 and pharmaceutically acceptable salts thereof 06-24-2010
107. 20100159587 ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2 - methods for their production 06-24-2010
108. 20100159489 PROMOTER - The current invention reports a promoter having the nucleic acid sequence of SEQ ID NO: 02 or SEQ ID NO: 03 06-24-2010
109. 20100158919 Pharmaceutical Composition - anti-IGF-1R human monoclonal antibody formulation a process for the preparation of said formulation and uses thereof 06-24-2010
110. 20100152462 PROCESS FOR THE PREPARATION OF PYROLLIDINE-3-CARBOXYLIC ACIDS 06-17-2010
111. 20100152193 PYRIDAZINONES - The present invention is concerned with novel pyridazinones of formula STR00001 wherein R 06-17-2010
112. 20100152190 Substituted Pyrrolidine-2-Carboxamides - There are provided compounds of the formula STR00001 wherein X, Y, R 06-17-2010
113. 20100144853 NOVEL COMBINED ADMINISTRATION - the combined administration of a thioester therapeutic agent and at least one esterase inhibitor 06-10-2010
114. 20100144762 NOVEL SULFONAMIDES AS L-CPT1 INHIBITORS - The invention is concerned with novel sulfonamide derivatives of formula STR00001 wherein R 06-10-2010
115. 20100144745 Pyrrolopyrazinyl Urea Kinase Inhibitors - the use of novel pyrrolopyrazinyl urea derivatives of Formula I, STR00001 wherein the variables R 06-10-2010
116. 20100137286 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES 06-03-2010
117. 20100137250 NAPHTHYLACETIC ACIDS - The invention is concerned with the compounds of formula I: STR00001 and pharmaceutically acceptable salts and esters thereof 06-03-2010
118. 20100137223 NEUROPEPTIDE-2 RECEPTOR (Y-2R) AGONISTS AND USES THEREOF 06-03-2010
119. 20100130484 NOVEL BICYCLIC SULFONAMIDE DERIVATIVES WHICH ARE L-CPT1 INHIBITORS 05-27-2010
120. 20100125078 QUINAZOLINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS 05-20-2010
121. 20100125066 ALKYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES 05-20-2010
122. 20100125061 NAPHTHYLACETIC ACIDS - The invention is concerned with the compounds of formula I: STR00001 and pharmaceutically acceptable salts and esters thereof 05-20-2010
123. 20100125058 NAPHTHYLACETIC ACIDS - The invention is concerned with the compounds of formula I: STR00001 and pharmaceutically acceptable salts and esters thereof 05-20-2010
124. 20100124547 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR VII GENES 05-20-2010
125. 20100121036 METHOD FOR THE PRODUCTION OF INSULIN-LIKE GROWTH FACTOR-1 05-13-2010
126. 20100120874 HETEROCYCLIC GAMMA SECRETASE MODULATORS - methods for the treatment of Alzheimer's disease cerebral amyloid angiopathy 05-13-2010
127. 20100120864 2-AMINOOXAZOLINES AS TAAR1 LIGANDS - compounds of formula I STR00001 wherein X, Y, R 05-13-2010
128. 20100120840 Heterocyclic benzylamino derivatives, their manufacture and use as pharmaceutical agents 05-13-2010
129. 20100120791 CYCLOHEXYL SULFONAMIDE DERIVATIVES - compounds of formula I STR00001 wherein R 05-13-2010
130. 20100120769 CYCLOHEXYL PIPERAZINYL METHANONE DERIVATIVES 05-13-2010
131. 20100120751 SPIRO-5,6-DIHYDRO-4H-2,3,5,10B-TETRAAZA-BENZO[E]AZULENES 05-13-2010
132. 20100119457 COMPOSITION OF LABELED AND NON-LABELED MONOCLONAL ANTIBODIES 05-13-2010
133. 20100113424 N-BENZYL PYRROLIDINE DERIVATIVES - compound of formula I STR00001 whereinAr, R 05-06-2010
134. 20100112603 METHOD FOR PREDICTING THE RESPONSE TO A TREATMENT 05-06-2010
135. 20100111967 BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES 05-06-2010
136. 20100111862 RADIOLABELLED INHIBITORS OF THE GLYCINE 1 TRANSPORTER 05-06-2010
137. 20100105906 NOVEL PHENYL AMIDE OR PYRIDYL AMIDE DERIVATIVES 04-29-2010
138. 20100105073 METHOD FOR THE PRODUCTION OF ANTIBODIES - The current invention is related to a method for the production of a human monoclonal antibody from a 04-29-2010
139. 20100099659 Inhibitors of Bruton's Tyrosine Kinase - This application discloses 5-phenyl-1H-pyridin-2-one and 6-phenyl-2H-pyridazin-3-one derivatives according to 04-22-2010
140. 20100094011 DIAZONIUM-FREE METHOD TO MAKE AN INDAZOLE INTERMEDIATE IN THE SYNTHESIS OF BICYCLIC 5-(TRIFLUORMETHOXY)-1H-3-INDAZOLECARBOXYLIC ACID AMIDES 04-15-2010
141. 20100093818 BENZIMIDAZOLE DERIVATIVES - The invention is concerned with novel benzimidazole derivatives of formula STR00001 wherein R 04-15-2010
142. 20100093808 SALT AND POLYMORPH OF A DPP-IV INHIBITOR 04-15-2010
143. 20100093731 MODULATORS FOR AMYLOID BETA - compounds of formula STR00001 wherein R 04-15-2010
144. 20100092947 Impdh2 snp associated with acute rejection 04-15-2010
145. 20100087654 PSEUDOPROLINE DIPEPTIDES - process for the manufacture of pseudo proline dipeptides of the formula STR00001 wherein R 04-08-2010
146. 20100087485 4-AMINOPIPERIDINE DERIVATIVES - compounds of the formula STR00001 wherein R 04-08-2010
147. 20100086912 AZGP Gene Single Nucleotide Polymorphisms (SNPs) 04-08-2010
148. 20100081796 BISPECIFIC ANTI-EGFR/ANTI-IGF-1R ANTIBODIES 04-01-2010
149. 20100076027 INDAZOLE OR 4,5,6,7-TETRAHYDRO-INDAZOLE DERIVATIVES 03-25-2010
150. 20100076026 3-AMINO-INDAZOLE OR 3-AMINO-4,5,6,7-TETRAHYDRO-INDAZOLE DERIVATIVES 03-25-2010
151. 20100075985 BENZO[D]ISOXAZOL-3-YL-PIPERAZIN DERIVATIVES USEFUL AS MODULATORS OF DOPAMINE D3 RECEPTORS 03-25-2010
152. 20100075983 D3 AND 5-HT2A RECEPTOR MODULATORS - compounds of the general formula STR00001 wherein X, n and R 03-25-2010
153. 20100075981 ISOXAZOLO[4,5]PYRIDIN-3-YL-PIPERAZIN DERIVATIVES USEFUL AS MODULATORS OF DOPAMINE D3 RECEPTORS 03-25-2010
154. 20100075979 PYRIDINYLPIPERAZIN DERIVATIVES USEFUL AS MODULATORS OF DOPAMINE D3 RECEPTORS 03-25-2010
155. 20100075959 BENZOTHIAZOLE DERIVATIVES WITH ACTIVITY AS ADENOSINE RECEPTOR LIGANDS 03-25-2010
156. 20100075954 SUBSTITUTED IMIDAZO[1,5-A][1,2,4]TRIAZOLO[1,5-D][1,4]BENZODIAZEPINE DERIVATIVES 03-25-2010
157. 20100075948 Substituted Pyrrolidine-2-Carboxamides - There are provided compounds of the formula STR00001 wherein X, Y, R 03-25-2010
158. 20100074903 NOVEL ANTIBODY FORMULATION - This invention relates to a pharmaceutical formulation of an antibody against P-Selectin a process for the preparation of 03-25-2010
159. 20100069413 Pyrimidine and Quinazoline Derivatives - This invention is concerned with compounds of the formula STR00001 wherein A, R 03-18-2010
160. 20100069328 NOVEL ORTHO-AMINOANILIDES FOR THE TREATMENT OF CANCER 03-18-2010
161. 20100069307 NEUROPEPTIDE-2 RECEPTOR (Y-2R) AGONISTS - Provided herein are neuropeptide-2 receptor agonists of the formula : Y--R 03-18-2010
162. 20100063101 NEW BENZIMIDAZOLE DERIVATIVES - The invention is concerned with novel benzimidazole derivatives of formula STR00001 wherein A, n and R 03-11-2010
163. 20100063042 5-SUBSTITUTED BENZOXAZINES - The present invention is concerned with 5-substituted benzoxazine derivatives of formula STR00001 wherein X, R 03-11-2010
164. 20100063037 6-SUBSTITUTED BENZOXAZINES - The present invention is concerned with 6-substituted benzoxazine derivatives of formula STR00001 wherein X, Y, R 03-11-2010
165. 20100056513 STEREOSPECIFICALLY SUBSTITUTED BENZO[1,3]DIOXOLYL DERIVATIVES 03-04-2010
166. 20100048569 DIAZOLE DERIVATIVES - of the general formula STR00001 wherein A, E, R 02-25-2010
167. 20100048531 GlyT1 RECEPTOR ANTAGONISTS - compound of formula I STR00001 wherein R 02-25-2010
168. 20100041886 ISOXAZOLO-PYRAZINE DERIVATIVES - and their pharmaceutically acceptable salts having affinity and selectivity for the GABA A 02-18-2010
169. 20100041760 MONOARYL AMINOTETRALINES - The invention is concerned with the compounds of formula I: STR00001 and pharmaceutically acceptable salts and esters 02-18-2010
170. 20100041714 BI-ARYL AMINOTETRALINES - The invention is concerned with the compounds of formula I: STR00001 and pharmaceutically acceptable salts and esters thereof, 02-18-2010
171. 20100041713 SUBSTITUTED AMINOTETRALINES - The invention is concerned with the compounds of formula I: STR00001 and pharmaceutically acceptable salts and esters 02-18-2010
172. 20100041686 4,5-DIHYDRO-OXAZOL-2YL DERIVATIVES - compounds of formula I STR00001 wherein R 02-18-2010
173. 20100041684 PYRIMIDYL DERIVATIVES AS PROTEIN KINASE INHIBITORS 02-18-2010
174. 20100041063 ANTI-DRUG ANTIBODY ASSAY - antibody binding specifically to Cynomolgus IgG characterized by not binding to Human IgG 02-18-2010
175. 20100035953 Pyrazole Phenyl Derivatives - compounds of the formula I: STR00001 wherein one of R 02-11-2010
176. 20100035817 METHOD FOR THE PRODUCTION OF CONJUGATES OF INSULIN-LIKE GROWTH FACTOR-1 AND POLY(ETHYLENE GLYCOL) 02-11-2010
177. 20100029664 PYRROLIDIN-3-YLMETHYL-AMINE AS OREXIN ANTAGONISTS 02-04-2010
178. 20100029589 4,5-DIHYDRO-OXAZOL-2YL DERIVATIVES - compounds of formula I STR00001 whereinR 02-04-2010
179. 20100028949 SHRNA-MEDIATED INHIBITION OF EXPRESSION OF ALPHA 1,6-FUCOSYLTRANSFERASE 02-04-2010
180. 20100022518 NOVEL HETEROCYCLYL COMPOUNDS - The invention is concerned with novel heterocyclyl compounds of formula : STR00001 wherein A, X, R 01-28-2010
181. 20100021965 Protein Expression in Rodent Cells - method is described for the expression of heterologous polypeptides in rodent cells 01-28-2010
182. 20100016369 AMINOTETRAHYDROINDAZOLOACETIC ACIDS - The invention is concerned with the compounds of formula I: STR00001 and pharmaceutically acceptable salts and 01-21-2010
183. 20100016368 AMINOTETRAHYDROINDAZOLOACETIC ACIDS - The invention is concerned with the compounds of formula I: STR00001 and pharmaceutically acceptable salts and 01-21-2010
184. 20100016325 TETRAHYDROCINNOLINE DERIVATIVES - Provided herein are compounds of formula : STR00001 as well as pharmaceutically acceptable salts and esters thereof 01-21-2010
185. 20100016282 NOVEL HETEROCYCLYL COMPOUNDS - The invention is concerned with novel heterocyclyl compounds of formula STR00001 wherein A, X, Y 01-21-2010
186. 20100015627 SELECTION METHOD - The current invention comprises a method for the selection of a mammalian cell by transfecting a mammalian cell with a nucleic acid 01-21-2010
187. 20100009462 Timp-2 as target/marker of beta cell failure 01-14-2010
188. 20100004297 NOVEL HEXAFLUOROISOPROPANOL DERIVATIVES - The invention is concerned with novel hexafluoroisopropanol derivatives of formula STR00001 wherein R 01-07-2010
189. 20090326253 NOVEL PHOSPHINE LIGANDS - The invention is concerned with new phosphine ligands of the formula I STR00001 wherein R 12-31-2009
190. 20090318474 PYRIDINE AND PYRIMIDINE DERIVATIVES AS MGLUR 2 ANTAGONISTS 12-24-2009
191. 20090318467 NOVEL HETEROARYL CARBOXAMIDE DERIVATIVES 12-24-2009
192. 20090318428 HETEROARYL DERIVATIVES AS PROTEIN KINASE INHIBITORS 12-24-2009
193. 20090318408 HALO-SUBSTITUTED PYRIMIDODIAZEPINES - PLK1 inhibitor compounds of formula I: STR00001 useful in the treatment or control of cell proliferative disorders 12-24-2009
194. 20090312569 NOVEL PROCESS - process for the preparation of 1--cyclohexanecarboxylic acid which is useful as an intermediate in the preparation of pharmaceutically 12-17-2009
195. 20090312382 NOVEL IMIDAZOLIDINE DERIVATIVES - The invention is concerned with novel imidazolidine derivatives of formula STR00001 wherein R 12-17-2009
196. 20090312327 PYRROLIDINE DERIVATIVES AS NK2 RECEPTOR ANTAGONISTS 12-17-2009
197. 20090312314 HETEROAROMATIC MONOAMIDES AS OREXININ RECEPTOR ANTAGONISTS 12-17-2009
198. 20090312289 IBANDRONATE POLYMORPH - new crystalline polymorph of 3-amino-1-hydroxypropane-1 1-diphosphonic acid monosodium salt monohydrate with the following 12-17-2009
199. 20090311779 ANTI-P-SELECTIN ANTIBODIES - This invention relates to anti-P-selectin antibodies and in particular to anti-P-selectin antibodies and variants thereof 12-17-2009
200. 20090311725 POLYPEPTIDE PRODUCING CELLS - The current invention describes a nucleic acid comprising in a 5' to 3' direction 12-17-2009
201. 20090306423 PROCESS FOR THE PREPARATION OF HALOGENATED BENZOIC ACID DERIVATIVES 12-10-2009
202. 20090306043 PYRROLIDINE ETHER DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS 12-10-2009
203. 20090304795 TABLETS WITH IMPROVED DRUG SUBSTANCE DISPERSIBILITY 12-10-2009
204. 20090291968 SUBSTITUTED INDAZOLE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS 11-26-2009
205. 20090286848 NOVEL N-(2-AMINO-PHENYL)-ACRYLAMIDES - the compounds of formula STR00001 wherein R 11-19-2009
206. 20090286812 GPR119 Receptor Agonists - Provided herein are compounds of the formula : STR00001 as well as pharmaceutically acceptable salts thereof 11-19-2009
207. 20090286235 Mdr1 Snp in Acute Rejection - The present invention concerns a method for the prediction of acute renal transplant rejection by detecting a polymorphism 11-19-2009
208. 20090286234 IL10 SNP ASSOCIATED WITH ACUTE REJECTION 11-19-2009
209. 20090275573 Imidazolidinone Derivatives as 11B-HSD1 Inhibitors 11-05-2009
210. 20090275126 ANTIBODIES AGAINST INSULIN-LIKE GROWTH FACTOR I RECEPTOR AND USES THEREOF 11-05-2009
211. 20090270506 CRYSTALLINE STRUCTURE OF OXIDOSQUALENE SYNTHASE 10-29-2009
212. 20090270505 4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES - This invention relates to novel 4-dimethylaminobutyric acid derivatives of the formula STR00001 wherein A 10-29-2009
213. 20090270500 4-TRIMETHYLAMMONIO-BUTYRATES AS CPT2 INHIBITORS 10-29-2009
214. 20090270360 DICARBOXAMIDE DERIVATIVES - The invention is concerned with novel dicarboxamide derivatives of formula STR00001 wherein A, B, R 10-29-2009
215. 20090264485 Pyrazole Derivatives, Their Manufacture and Their Use as Pharmaceutical Agents 10-22-2009
216. 20090264445 PYRROLIDINONE GLUCOKINASE ACTIVATORS - Provided herein are compounds of the formula : STR00001 as well as pharmaceutically acceptable salts thereof 10-22-2009
217. 20090264434 PYRIDAZINONE GLUCOKINASE ACTIVATORS - Provided herein are compounds of the formula : STR00001 as well as pharmaceutically acceptable salts thereof 10-22-2009
218. 20090264418 5-AMIDO-INDOLE-2-CARBOXAMIDE DERIVATIVES 10-22-2009
219. 20090253928 PREPARATION FOR A CYCLOHEXANECARBOXYLIC ACID DERIVATIVE AND INTERMEDIATES 10-08-2009
220. 20090253927 PROCESS FOR CYCLOHEXANECARBOXYLIC ACID DERIVATIVES 10-08-2009
221. 20090253698 Brain, Spinal and Nerve Injury Treatment 10-08-2009
222. 20090253684 LEUKOTRIENE B4 INHIBITORS - Provided herein are compounds of the formula : STR00001 as well as pharmaceutically acceptable salts thereof 10-08-2009
223. 20090253628 Use of PEGylated IGF-I variants for the treatment of neuromuscular disorders 10-08-2009
224. 20090253150 Three Part Assay for Kinase or Phosphatase Activity 10-08-2009
225. 20090247637 Novel Anthranilic Acid Derivatives - The invention is concerned with novel anthranilic acid derivatives of formula STR00001 wherein R 10-01-2009
226. 20090247588 2-TRIFLUOROMETHYLNICOTINAMIDE DERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTS 10-01-2009
227. 20090247550 3-TRIFLUOROMETHYL-PYRAZINE-2-CARBOXYLIC ACID AMIDE DERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTS 10-01-2009
228. 20090247518 6-(2-ALKYL-PHENYL)-PYRIDO[2,3-D]PYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS 10-01-2009
229. 20090246197 COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC) 10-01-2009
230. 20090240080 PROCESS FOR THE PREPARATION OF CETP(1) - process for the preparation of 1--cyclohexanecarboxylic acid which is useful as an intermediate in the 09-24-2009
231. 20090239889 Spiroindolinone Derivatives - There are provided compounds of the general formulas STR00001 wherein W, X, Y, R 09-24-2009
232. 20090232811 BIVALENT, BISPECIFIC ANTIBODIES - novel domain exchanged, bivalent, bispecific antibodies, their manufacture and use 09-17-2009
233. 20090221599 PHTHALAZINONE PYRAZOLE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS 09-03-2009
234. 20090215826 SOLID FORMS OF A PYRROLIDINE-3,4-DICARBOXAMIDE DERIVATIVE 08-27-2009
235. 20090215759 MODULATORS FOR AMYLOID BETA - compounds of formula STR00001 wherein the substituents are as described in claim 1 08-27-2009
236. 20090215069 Pancreatic polypeptide as target/marker of beta cell failure 08-27-2009
237. 20090209529 4,5-DIHYDRO-OXAZOL-2-YL AMINE DERIVATIVES 08-20-2009
238. 20090208971 Insulin promoter factor 1 as target/marker of beta cell failure 08-20-2009
239. 20090203736 PIPERIDINE SULPHONAMIDE DERIVATIVES - of formula STR00001 wherein Ar 08-13-2009
240. 20090203681 NOVEL N-(2-AMINO-PHENYL)-AMIDE DERIVATIVES 08-13-2009
241. 20090203665 HETEROCYCLIC-SUBSTITUTED PHENYL METHANONES 08-13-2009
242. 20090197875 ARYL-ISOXAZOLO-4-YL-OXADIAZOLE DERIVATIVES 08-06-2009
243. 20090192333 PROCESS FOR THE PREPARATION OF ACID HALIDES 07-30-2009
244. 20090192136 BENZOYL-PIPERAZINE DERIVATIVES - compound of formula STR00001 wherein the substituents are as described in the specification for the treatment of 07-30-2009
245. 20090191187 ANTIBODIES AGAINST INTERLEUKIN-1 RECEPTOR AND USES THEREOF 07-30-2009
246. 20090186920 SULFONAMIDES AS OREXIN ANTAGONISTS - The present invention is concerned with novel sulfonamides of formula STR00001 wherein R 07-23-2009
247. 20090181965 MODULATORS FOR AMYLOID BETA - compounds of formula STR00001 wherein R 07-16-2009
248. 20090181944 METHOD FOR CANCER THERAPY - method for treating a patient having cancer comprising administering to the patient a therapeutically effective amount of 07-16-2009
249. 20090175851 BIVALENT, BISPECIFIC ANTIBODIES - novel domain exchanged, bivalent, bispecific antibodies, their manufacture and use 07-09-2009
250. 20090171100 METHOD FOR PREPARING ENANTIOMERICALLY PURE 4-PYRROLIDINO PHENYLBENZYL ETHER DERIVATIVES 07-02-2009
251. 20090170920 SUBSTITUTED HYDANTOINS - compounds of the formula STR00001 methods for the preparation thereof, and methods for their use 07-02-2009
252. 20090170864 Diacylglycerol Acyltransferase Inhibitors 07-02-2009
253. 20090163552 CARBOXYL- OR HYDROXYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES 06-25-2009
254. 20090163546 DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS 06-25-2009
255. 20090163517 BENZOOXAZOLE, OXAZOLOPYRIDINE, BENZOTHIAZOLE AND THIAZOLOPYRIDINE DERIVATIVES 06-25-2009
256. 20090163512 Spiroindolinone Derivatives - There are provided compounds of the formula STR00001 and pharmaceutically acceptable salts and esters and enantiomers 06-25-2009
257. 20090163485 HETEROARYL DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS 06-25-2009
258. 20090162360 BIVALENT, BISPECIFIC ANTIBODIES - novel domain exchanged, bivalent, bispecific antibodies, their manufacture and use 06-25-2009
259. 20090162359 BIVALENT, BISPECIFIC ANTIBODIES - novel domain exchanged, bivalent, bispecific antibodies, their manufacture and use 06-25-2009
260. 20090162352 ANTIBODY FORMULATION - pharmaceutical formulation comprising an anti-CD20 antibody 06-25-2009
261. 20090156635 BIARYLOXYMETHYLARENECARBOXYLIC ACIDS AS GLYCOGEN SYNTHASE ACTIVATORS 06-18-2009
262. 20090156610 Spiroindolinone Derivatives - There are provided compounds of the formula STR00001 and pharmaceutically acceptable salts and esters thereof wherein W 06-18-2009
263. 20090156583 Tricyclic Amide Derivatives - compounds of formula I STR00001 wherein A, G, r and R 06-18-2009
264. 20090155356 THIXOTROPIC OIL BASED VEHICLE FOR PHARMACEUTICAL COMPOSITIONS 06-18-2009
265. 20090149503 NEW 5-ARYL PYRIDINES AS 11-BETA INHIBITORS FOR THE TREATMENT OF DIABETES 06-11-2009
266. 20090149466 INHIBITORS OF STEAROYL-COA DESATURASE - Provided herein are compounds of the formula : STR00001 as well as pharmaceutically acceptable salts thereof 06-11-2009
267. 20090143580 SUBSTITUTED PYRAZOLO [1,5-a] PYRIMIDINES AS METABOTROPIC GLUTAMATE ANTAGONISTS 06-04-2009
268. 20090143448 NEW AMINOTHIAZOLES AS FBPASE INHIBITORS FOR DIABETES 06-04-2009
269. 20090143439 NEW PYRIDINES AS FBPASE INHIBITORS FOR TREATMENT OF DIABETES 06-04-2009
270. 20090143409 3-PYRIDINECARBOXAMIDE DERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTS 06-04-2009
271. 20090143407 ISOXAZOLO-PYRAZINE DERIVATIVES - and their pharmaceutically acceptable salts having affinity and selectivity for the GABA A 06-04-2009
272. 20090143385 ISOXAZOLO-PYRIDAZINE DERIVATIVES - isoxazolo-pyridazine compounds in particular those of formula I as described above and to a pharmaceutically 06-04-2009
273. 20090143375 Tricyclic Lactam Derivatives, Their Manufacture and Use as Pharmaceutical Agents 06-04-2009
274. 20090143371 ISOXAZOLE-PYRIDINE DERIVATIVES - The present invention is concerned with isoxazole-pyridine derivatives of formula I STR00001 wherein X, R 06-04-2009
275. 20090143364 CHIRAL CIS-IMIDAZOLINES - and the pharmaceutically acceptable salts and esters thereof, wherein X 06-04-2009
276. 20090137806 DUAL NK1/NK3 RECEPTOR ANTAGONISTS - method for the treatment of schizophrenia which comprises administering a compound of formula STR00001 wherein the 05-28-2009
277. 20090136939 Methods for diagnosis and therapy for pancreatic cancer and composition useful therein 05-28-2009
278. 20090131482 METHYL-BENZIMIDAZOLE DERIVATIVES - The invention is concerned with novel substituted benzimidazole derivatives of formula STR00001 wherein R 05-21-2009
279. 20090130770 BIOMARKER FOR FARNESYL PATHWAY - novel biomarker which can be used to determine the extent of interference of a substance with the farnesyl pathway 05-21-2009
280. 20090130660 Single Nucelotide Polymorphism (SNP) - Association of Type 2 diabetes with single nucleotide polymorphisms and haplotypes are disclosed 05-21-2009
281. 20090123943 Characterization and Identification of Unique Human Adiponectin Isoforms and Antibodies 05-14-2009
282. 20090118546 METHODS FOR STABILIZING LITHIATED HALOGEN-SUBSTITUTED AROMATIC COMPOUNDS 05-07-2009
283. 20090118476 Purification of pegylated polypeptides - The invention is a method for the purification of mono-PEGylated erythropoietin using two cation exchange 05-07-2009
284. 20090117662 Mutants of IGF Binding Proteins and Methods of Production of Antagonists Thereof 05-07-2009
285. 20090111789 CHIRAL CIS-IMIDAZOLINES - There are provided compounds of the formula STR00001 or the pharmaceutically acceptable salts thereof, wherein X, Y, Z, V 04-30-2009
286. 20090110688 COMBINATION THERAPY OF TYPE II ANTI-CD20 ANTIBODY WITH A PROTEASOME INHIBITOR 04-30-2009
287. 20090105480 PROCESS FOR THE PREPARATION OF A DPP-IV INHIBITOR 04-23-2009
288. 20090105477 Quinazoline Protein Tyrosine Phosphatase Inhibitors 04-23-2009
289. 20090105307 2-AMINOOXAZOLINES AS TAAR1 LIGANDS - compounds of formula STR00001 wherein R 04-23-2009
290. 20090105273 Diacylglycerol Acyltransferase Inhibitors 04-23-2009
291. 20090099201 Diacylglycerol Acyltransferase Inhibitors 04-16-2009
292. 20090098660 Method for the Purification of Antibodies 04-16-2009
293. 20090098118 COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH AN ANTI-BCL-2 ACTIVE AGENT 04-16-2009
294. 20090093497 Diacylglycerol Acyltransferase Inhibitors 04-09-2009
295. 20090093491 Diazine Azole Derivatives, Their Manufacture and Use as Pharmaceutical 04-09-2009
296. 20090088459 NOVEL BIARYL SULFONAMIDE DERIVATIVES - The invention is concerned with novel biaryl sulfonamide derivatives of formula STR00001 wherein R 04-02-2009
297. 20090088451 QUINOLINES - 2-aminoquinolines of formula I STR00001 wherein R 04-02-2009
298. 20090088425 GLUCOCORTICOID RECEPTOR ANTAGONISTS - compounds of formula I STR00001 wherein A, n, R 04-02-2009
299. 20090082310 PRODRUGS OF THYROID HORMONE ANALOGS - Provided herein are compounds of the formula : STR00001 as well as pharmaceutically acceptable salts thereof 03-26-2009
300. 20090076275 DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS 03-19-2009
301. 20090076081 PIPERIDINE DERIVATIVES AS NK3 ANTAGONISTS 03-19-2009
302. 20090069311 5-AMINOINDOLE DERIVATIVES AS H3 INVERSE AGONISTS 03-12-2009
303. 20090062356 SUBSTITUTED BENZIMIDAZOLE DERIVATIVES - The invention is concerned with novel substituted benzimidazole derivatives of formula STR00001 wherein R 03-05-2009
304. 20090062276 PYRIDOPYRIMIDINE PROTEIN TYROSINE PHOSPHATASE INHIBITORS 03-05-2009
305. 20090061466 ANTI-DRUG ANTIBODY ASSAY - method for the immunological determination of an antibody against a drug antibody in a sample using a double antigen bridging 03-05-2009
306. 20090060913 COMBINATION THERAPY WITH TYPE I AND TYPE II ANTI-CD20 ANTIBODIES 03-05-2009
307. 20090054644 PYRROLIDINE ARYL-ETHER AS NK3 RECEPTOR ANTAGONISTS 02-26-2009
308. 20090054490 METHODS FOR THE TREATMENT OF GERD WITH MGLUR5 ANTAGONISTS 02-26-2009
309. 20090054481 Saquinavir Mesylate Oral Dosage Form - solid unit oral pharmaceutical dosage form of saquinavir mesylate is provided comprising micronized saquinavir 02-26-2009
310. 20090054466 Leukotriene B4 Inhibitors - Provided herein are compounds of the formula : STR00001 as well as pharmaceutically acceptable salts thereof 02-26-2009
311. 20090048452 SUBSTITUTED HYDANTOINS - This invention relates to compounds of formula I: STR00001 or pharmaceutically acceptable salts thereof 02-19-2009
312. 20090048274 PYRAZOLO[3,4-d]PYRIMIDINE DERIVATIVES - Disclosed are novel pyrazolo[3,4-d]pyrimidine derivatives that are inhibitors of Raf kinase 02-19-2009
313. 20090048264 PIPERAZINE AMIDE DERIVATIVES - The invention is concerned with novel piperazine amide derivatives of formula STR00001 wherein R 02-19-2009
314. 20090048238 NOVEL BIARYL DERIVATIVES - The invention is concerned with novel biaryl derivatives of formula , STR00001 wherein STR00002 m, R 02-19-2009
315. 20090042943 BENZOYL-PIPERIDINE DERIVATIVES AS DUAL MODULATORS OF THE 5-HT2A AND D3 RECEPTORS 02-12-2009
316. 20090042903 PIPERAZINYL-PYRIDINE DERIVATIVES - compounds of formula I STR00001 wherein R 02-12-2009
317. 20090042896 PYRROLIDINE ARYL-ETHER AS NK3 RECEPTOR ANTAGONISTS 02-12-2009
318. 20090036703 PROCESS FOR THE PRODUCTION OF ACID CHLORIDES 02-05-2009
319. 20090036452 TAAR1 LIGANDS - compound of formula STR00001 wherein R 02-05-2009
320. 20090036422 MONOAMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS 02-05-2009
321. 20090036420 BENZAMIDE DERIVATIVES AND THEIR USE FOR TREATING CNS DISORDERS 02-05-2009
322. 20090030020 7H-Pyrido[3,4-D]Pyrimidin-8-Ones, Their Manufacture and Use as Protein Kinase Inhibitors 01-29-2009
323. 20090029977 DUAL MODULATORS OF 5HT2A AND D3 RECEPTORS 01-29-2009
324. 20090029976 BENZOFURAN AND BENZOTHIOPHENE-2-CARBOXYLIC ACID AMIDE DERIVATIVES 01-29-2009
325. 20090029963 PYRAZOL DERIVATIVES - The invention is concerned with novel pyrazol derivatives of formula , STR00001 wherein STR00002 R 01-29-2009
326. 20090029962 2-AZETIDINEMETHANEAMINES AND 2-PYRROLIDINEMETHANEAMINES AS TAAR-LIGANDS 01-29-2009
327. 20090023713 HETEROCYCLIC COMPOUNDS - The invention is concerned with novel heterocyclyl compounds of formula STR00001 wherein A, X, Y, R 01-22-2009
328. 20090023709 Inhibitors of 11B-Hyrdoxysteroid Dehydrogenase 01-22-2009
329. 20090018312 IGF-1 RECEPTOR INTERACTING PROTEINS - The invention comprises a nucleic acid molecule with the sequence SEQ ID NO:5 and the complementary sequence, and 01-15-2009
330. 20090018180 2-IMIDAZOLINES 01-15-2009
331. 20090018171 IMIDAZOLE DERIVATIVES - of formula I STR00001 wherein R 01-15-2009
332. 20090012311 PROCESS FOR THE PREPARATION OF INDOLE DERIVATIVES 01-08-2009
333. 20090012138 4-IMIDAZOLINES - compounds of formula STR00001 wherein R 01-08-2009
334. 20090012063 Novel imidazole derivatives - The invention is concerned with novel imidazole derivatives of formula , STR00001 wherein STR00002 m, E, R 01-08-2009
335. 20090005383 THYROID HORMONE ANALOGS - Provided herein are compounds of the formula : STR00001 as well as pharmaceutically acceptable salts thereof 01-01-2009
336. 20090005380 CYCLOHEXYL DERIVATIVES - compounds of formula I STR00001 wherein R 01-01-2009
337. 20090005379 Azaindole-2-Carboxamide Derivatives - compounds of formula wherein R 01-01-2009
338. 20090005370 ISOXAZOLE-IMIDAZOLE DERIVATIVES - The present invention is concerned isoxazole-imidazole derivatives having affinity and selectivity for GABA A 01-01-2009
339. 20080317714 Method of Treating Hepatitis B Viral Infection 12-25-2008
340. 20080312467 NOVEL PROCESS FOR THE PREPARATION OF 3-AMINO-PENTAN-1,5-DIOL 12-18-2008
341. 20080312288 SOLID FORMS OF 2-CHLORO-4-[1-(4-FLUORO-PHENYL)-2,5-DIMETHYL-1H-IMIDAZOL-4-YLETHYNYL]-PYRIDINE 12-18-2008
342. 20080312216 PIPERAZINE AND [1,4]DIAZEPAN DERIVATIVES AS NK ANTAGONISTS 12-18-2008
343. 20080306116 ARYLOXAZOLE, ARYLOXADIAZOLE AND BENZIMIDAZOLE DERIVATIVES 12-11-2008
344. 20080306089 PROLINAMIDE-TETRAZOLE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS 12-11-2008
345. 20080306086 PROLINAMIDE DERIVATIVES AS NK3 ANTAGONISTS 12-11-2008
346. 20080300279 PIPERIDINE-AMIDE DERIVATIVES - The invention is concerned with novel piperidine-amide derivatives of formula wherein R 12-04-2008
347. 20080300250 ACETYLENYL-PYRAZOLO-PYRIMIDINE DERIVATIVES 12-04-2008
348. 20080293933 PROCESS FOR PREPARATION OF ENANTIOMERICALLY PURE COMPOUNDS 11-27-2008
349. 20080293787 PHARMACEUTICAL COMPOSITIONS FOR POORLY SOLUBLE DRUGS 11-27-2008
350. 20080293756 4,4-DISUBSTITUTED PIPERIDINE DERIVATIVES 11-27-2008
351. 20080293723 SPIROINDOLINONE DERIVATIVES - There are provided spiroindolinone derivatives of the formula and pharmaceutically acceptable salts and esters 11-27-2008
352. 20080287455 SULFANYL SUBSTITUTED PHENYL METHANONES - compounds of formula I whereinR 11-20-2008
353. 20080287421 3,3-SPIROINDOLINONE DERIVATIVES - There are provided compounds of the general formulas wherein X, Y, R 11-20-2008
354. 20080281103 AZASPIRO DERIVATIVES - The present invention is concerned with novel indol-3-yl-carbonyl-azaspiropiperidine derivatives as V1a receptor antagonists 11-13-2008
355. 20080280948 MODULATORS OF AMYLOID BETA - compounds of formula wherein hetaryl I, hetaryl II, and R 11-13-2008
356. 20080280924 PYRIDINE AND PYRIMIDINE DERIVATIVES AS MGLUR2 ANTAGONISTS 11-13-2008
357. 20080280898 Spiro-piperidine derivatives - The present invention is concerned with novel spiro-piperidine derivatives as V1a receptor antagonists 11-13-2008
358. 20080275220 METHOD FOR STABILIZING A PROTEIN - method for stabilizing an aqueous protein solution against exogenous stress and to the use of a container for 11-06-2008
359. 20080275021 PYRROLIDINE DERIVATIVES AS DUAL NK1/NK3 RECEPTOR ANTAGONISTS 11-06-2008
360. 20080269517 PROCESS FOR THE PREPARATION OF ACID HALIDES 10-30-2008
361. 20080269290 Indoles - The present invention is concerned with novel indol-2-yl-carbonyl-piperidin-benzoimidazolon and indol-2-yl-carbonyl-piperidin-benzoxazolon 10-30-2008
362. 20080269256 PYRIDINE-2-CARBOXYAMIDE DERIVATIVES - compounds of formula I: wherein R 10-30-2008
363. 20080261957 DIHYDRO-BENZO[B][1,4]DIAZEPIN-2-ONE SULFONAMIDE DERIVATIVES 10-23-2008
364. 20080261924 METHOD FOR THE TREATMENT OF BONE DISORDERS 10-23-2008
365. 20080261920 2-Aminooxazolines as TAAR1 ligands - compounds of formula I whereinX, Y, R 10-23-2008
366. 20080260827 RISEDRONATE COMPOSITIONS AND THEIR METHODS OF USE 10-23-2008
367. 20080255386 PROCESS FOR PREPARING IBANDRONATE - novel multi step synthesis of 3-amino-1-hydroxypropane-1 1-diphosphonic acid 10-16-2008
368. 20080255198 BIARYLOXYMETHYLARENECARBOXYLIC ACIDS AS GLYCOGEN SYNTHASE ACTIVATOR 10-16-2008
369. 20080255119 DIPHENYL-DIHYDRO-IMIDAZOPYRIDINONES - and the pharmaceutically acceptable salts and esters thereof X, R 10-16-2008
370. 20080249180 MALONAMIDES AS OREXIN ANTAGONISTS - compounds of formula I wherein Ar 10-09-2008
371. 20080249125 HETEROCYCLIC DERIVATIVES AS OREXIN ANTAGONISTS 10-09-2008
372. 20080249101 BENZOIMIDAZOLE, TETRAHYDRO-QUINOXALINE, BENZOTRIAZOLE, DIHYDRO-IMIDAZO[4,5-c] PYRIDINONE AND DIHYDRO-ISOINDOLONE DERIVATIVES 10-09-2008
373. 20080249069 METHOD OF TREATMENT USING BISPHOSPHONIC ACID 10-09-2008
374. 20080248537 BIOCATALYTIC ASYMMETRIC REDUCTION IN PREPARATION OF (S)-N-[5-(1,2-DIHYDROXY-ETHYL)-PYRAZINYL]-2,2-DIMETHYL-PROPIONAMIDE 10-09-2008
375. 20080248510 HUMAN Fc GAMMA RECEPTOR III - the field of human immunoglobulin receptors specifically the glycostructure of a human Fc gamma receptor IIIa 10-09-2008
376. 20080248468 Method for Improved Selection of Rnai Transfectants 10-09-2008
377. 20080242677 IMIDAZOLIDINONE DERIVATIVES - The invention is concerned with novel imidazolidinone derivatives of formula : wherein R 10-02-2008
378. 20080234356 2-PHENYL-3,3,3-TRIFLUORO-2-HYDROXY-PROPIONIC ACID DERIVATIVES 09-25-2008
379. 20080234290 NEW INDOLE OR BENZIMIDAZOLE DERIVATIVES AS CB1 INVERSE AGONISTS 09-25-2008
380. 20080234277 NOVEL AZA-PYRIDOPYRIMIDINONE DERIVATIVES 09-25-2008
381. 20080234255 SUBSTITUTED PYRIMIDODIAZEPINES - PLK1 inhibitor compounds of formula I: Useful in the treatment or control of cell proliferative disorders 09-25-2008
382. 20080226635 Antibodies against insulin-like growth factor I receptor and uses thereof 09-18-2008
383. 20080221327 SYNTHESIS OF GLYT-1 INHIBITORS - process for preparation of a compound of formula I wherein Het, R 09-11-2008
384. 20080221166 AMINOAMIDES AS OREXIN ANTAGONISTS - compounds of formula I wherein Ar 09-11-2008
385. 20080214826 PROCESSES FOR THE MANUFACTURE OF A PYRROLIDINE-3,4-DICARBOXAMIDE DERIVATIVE 09-04-2008
386. 20080214561 SOLID FORMS OF [4-(3-FLUORO-5-TRIFLUOROMETHYL-PYRIDIN-2-YL)-PIPERAZIN-1-YL-[5-METHANESULFONYL-2-((S)-2,2,2-TRIFLUORO-1-METHYL-ETHOXY)-PHENYL]-METHANONE 09-04-2008
387. 20080214505 Risedronate compositions and their methods of use 09-04-2008
388. 20080207563 METHOD FOR INHIBITING PROLIFERATION OF TUMOR CELLS 08-28-2008